Regen BioPharma Inc (OTCMKTS: RGBP) Share Going Up the Charts Again

July 7, 2021

Regen BioPharma Inc (OTCMKTS: RGBP) share has started going up the charts as it broke it’s high and looked to break out of its trading range and make a run on its recent highs of $0.081 in April.  Stock market high achieved after company subsidiary enters agreement with Oncology Pharma Inc (OTCMKTS: ONPH) The high was achieved after Regen, and its subsidiary KLS arrived into an agreement with Oncology Pharma…

Read More >>

Pardes Biosciences and FS Development II Corp (NASDAQ: FSII) Announce Union Contract

July 2, 2021

Pardes Biosciences, Inc., an early-stage biopharmaceutical corporation, and FS Development II Corp (NASDAQ: FSII), a unique purpose purchase business backed by Foresite Capital, today announced they have arrived into a conclusive merger contract.  In Conclusion of a deal new company to be called Pardes Biosciences, Inc Upon finishing the deal, the company will be retitled “Pardes Biosciences, Inc.” and led by Uri A. Lopatin, M.D., Chief Executive Officer of Pardes….

Read More >>